Cat. No. | Product Name | CAS No. | Purity | Chemical Structure |
---|---|---|---|---|
T14947 | CHDI-390576
化合物 T14947
|
1629729-98-1 | 98% |
|
CHDI-390576 is a CNS penetrant class IIa HDAC inhibitor (IC50s: 54 nM, 60 nM, 31 nM, 50 nM for class IIa HDAC4, HDAC5, HDAC7, HDAC9). It shows >500-fold selectiv... | ||||
T14936 | Ivaltinostat
化合物 T14936
|
936221-33-9 | 98% |
|
CG-200745 is a potent inhibitor of HDAC. CG200745 induces apoptosis and also inhibits the deacetylation of histone H3 and tubulin. | ||||
T11542 | HDAC-IN-4
化合物 T11542
|
1252003-13-6 | 98% |
|
HDAC-IN-4 is a selective HDAC6 and HDAC10 inhibitor (pIC50s: 7.2 and 6.8 in BRET assay) with antitumoral activity. | ||||
T10602 | BRD 4354 ditrifluoroacetate
化合物 T10602
|
T10602 | 98% |
|
BRD 4354 (ditrifluoroacetate) is a moderately potent inhibitor of HDAC5 and HDAC9 (IC50s: 0.85 and 1.88 μM). | ||||
T2S0606 | Bakkenolide A
蜂斗菜内酯A
|
19906-72-0 | 98% |
|
Bakkenolide A has antifeedant and growth inhibitory effects on neonate variegated cutworms, it inhibits leukemia by regulation of HDAC3 and PI3K/Akt-related sign... | ||||
T11543 | HDAC-IN-5
化合物 T11543
|
1314890-51-1 | 98% |
|
HDAC-IN-5 is a histone deacetylase (HDAC) inhibitor. | ||||
T11544 | HDACs/mTOR Inhibitor 1
化合物 T11544
|
2271413-06-8 | 98% |
|
HDACs/mTOR Inhibitor 1 is a dual HDACs and mammalian target of Rapamycin (mTOR) target inhibitor for treating hematologic malignancies (IC50s: 0.19 nM, 1.8 nM, 1... | ||||
T72872 | HDAC/BET-IN-1
化合物 HDAC/BET-IN-1
|
2757573-68-3 | 98% |
|
HDAC/BET-IN-1表现出对HDAC1 (IC50= 0.163 μM) 和HDAC6 (IC50= 0.067 μM) 的亚微摩尔级别抑制作用,以及对BRD4 (Ki= 0.076 μM) 的抑制活性,同时也显示出显著的抗白血病活性。 | ||||
T73454 | SAHA-OH
化合物 SAHA-OH
|
2857098-30-5 | 98% |
|
SAHA-OH为HDAC6选择性抑制剂(IC50=23 nM),对HDAC6具有10至47倍选择性,相较于HDAC1、2、3及8。该化合物展现抗炎活性,能够降低巨噬细胞凋亡。 | ||||
T74617 | HDAC6-IN-8
化合物 HDAC6-IN-8
|
2796282-49-8 | 98% |
|
Compound 12c has been synthesized with modifications to the Cap group and exhibits broad-spectrum enzyme inhibitory activity as evidenced by enzyme inhibition as... | ||||
T74783 | HDAC-IN-53
化合物 HDAC-IN-53
|
2921948-27-6 | 98% |
|
HDAC-IN-53是一种口服活性的选择性HDAC1-3抑制剂,其IC50分别为47 nM、125 nM和450 nM。该化合物不针对II类HDAC(HDAC4、5、6、7、9;IC50>10 μM)展现抑制作用。HDAC-IN-53能够诱导caspase依赖的细胞凋亡并在裸鼠中显著抑制人肿瘤异种移植物生长,同时抑制携带... | ||||
T9959 | Suprastat
化合物Suprastat
|
90093-40-6 | 98% |
|
Suprastat 是一种 HDAC6 抑制剂,可用于计算机模拟。 | ||||
T6637 | Resminostat
马西替坦
|
864814-88-0 | 98% |
|
Resminostat (4SC-201) 是一种可口服的HDAC1、HDAC3和HDAC6抑制剂,IC50值分别为 42.5、50.1和71.8 nM,具有潜在抗肿瘤活性。 | ||||
T16805 | RTS-V5
化合物 T16805
|
2285346-31-6 | 98% |
|
RTS-V5 is a dual inhibitor of HDAC/proteasome (IC50s: 6.9, 18, 15, 0.27, 0.53 μM for HDAC1, HDAC2, HDAC3, HDAC6, HDAC8, respectively). | ||||
T16415 | Oxamflatin
化合物 T16415
|
151720-43-3 | 98% |
|
Oxamflatin is an effective inhibitor of HDAC (IC50: 15.7 nM). | ||||
T2205 | Acefylline
茶碱乙酸
|
652-37-9 | 99.95% |
|
Acefylline (Theophylline-7-acetic acid) 是黄嘌呤衍生物,是一种腺苷受体拮抗剂。它是蛋白质精氨酸脱亚氨酶 (PAD) 激活剂,也是一种支气管扩张剂,可抑制大鼠肺 cAMP 磷酸二酯酶同工酶。 | ||||
T2157 | M344
化合物Histone Deacetylase Inhibitor III
|
251456-60-7 | 99.95% |
|
M344 (Histone Deacetylase Inhibitor III) 是一种组蛋白去乙酰化酶抑制剂,IC50为 100 nM。 | ||||
T1583 | Vorinostat
伏立诺他
|
149647-78-9 | 99.93% |
|
Vorinostat (suberoylanilide hydroxamic acid) 是一种具有抗肿瘤活性的组蛋白脱乙酰酶泛抑制剂,IC50值约为 10 nM。 | ||||
T1852 | Rac-Belinostat
化合物Belinostat
|
414864-00-9 | 99.93% |
|
Rac-Belinostat (PX-105684) 是一种具有抗肿瘤活性的新型异羟肟酸型组蛋白脱乙酰酶 (HDAC) 抑制剂。 Belinostat 靶向 HDAC 酶,从而抑制肿瘤细胞增殖、诱导细胞凋亡、促进细胞分化和抑制血管生成。这种药物可以使耐药肿瘤细胞对其他抗肿瘤药物敏感,可能是通过一种涉及胸苷酸合酶下调的机制... | ||||
T1535 | Sodium 4-phenylbutyrate
苯丁酸钠
|
1716-12-7 | 99.92% |
|
Sodium 4-phenylbutyrate (TriButyrate) 是一种组蛋白去乙酰化酶和内质网应激抑制剂,可研究癌症和感染等疾病。 |